Pediatric high-grade glioma MYCN is frequently associated with Li-Fraumeni syndrome
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2051-5960
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Pediatric high-grade glioma MYCN is frequently associated with Li-Fraumeni syndrome ; volume:11 ; number:1 ; day:6 ; month:1 ; year:2023 ; pages:1-4 ; date:12.2023
Acta Neuropathologica Communications ; 11, Heft 1 (6.1.2023), 1-4, 12.2023
- Urheber
-
Guerrini-Rousseau, Léa
Tauziède-Espariat, Arnault
Castel, David
Rouleau, Etienne
Sievers, Philipp
Saffroy, Raphaël
Beccaria, Kévin
Blauwblomme, Thomas
Hasty, Lauren
Bourdeaut, Franck
Grill, Jacques
Varlet, Pascale
Debily, Marie-Anne
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s40478-022-01490-w
- URN
-
urn:nbn:de:101:1-2023031522083741669549
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:57 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Guerrini-Rousseau, Léa
- Tauziède-Espariat, Arnault
- Castel, David
- Rouleau, Etienne
- Sievers, Philipp
- Saffroy, Raphaël
- Beccaria, Kévin
- Blauwblomme, Thomas
- Hasty, Lauren
- Bourdeaut, Franck
- Grill, Jacques
- Varlet, Pascale
- Debily, Marie-Anne
- SpringerLink (Online service)
Ähnliche Objekte (12)
Refinement of diagnostic criteria for pediatric-type diffuse high-grade glioma, IDH- and H3-wildtype, MYCN-subtype including histopathology, TP53, MYCN and ID2 status
An integrative radiological, histopathological and molecular analysis of pediatric pontine histone-wildtype glioma with MYCN amplification (HGG-MYCN)
Signaling pathways and mesenchymal transition in pediatric high-grade glioma
Pediatric Non–Brain Stem High-Grade Glioma: A Single-Center Experience
Mouse models of pediatric high-grade gliomas with MYCN amplification reveal intratumoral heterogeneity and lineage signatures
How I treat recurrent pediatric high-grade glioma (pHGG): a Europe-wide survey study
How I treat recurrent pediatric high-grade glioma (pHGG): a Europe-wide survey study
Computational multi-omics analysis of pediatric DADDR patients and synthetic lethality prediction in K27M mutated pediatric high-grade glioma
Multifocal high-grade glioma radiotherapy safety and efficacy
The pediatric supratentorial MYCN-amplified high-grade gliomas methylation class presents the same radiological, histopathological and molecular features as their pontine counterparts
Capmatinib is an effective treatment for MET-fusion driven pediatric high-grade glioma and synergizes with radiotherapy
A prognostic neural epigenetic signature in high-grade glioma
Refinement of diagnostic criteria for pediatric-type diffuse high-grade glioma, IDH- and H3-wildtype, MYCN-subtype including histopathology, TP53, MYCN and ID2 status
An integrative radiological, histopathological and molecular analysis of pediatric pontine histone-wildtype glioma with MYCN amplification (HGG-MYCN)
Signaling pathways and mesenchymal transition in pediatric high-grade glioma
Pediatric Non–Brain Stem High-Grade Glioma: A Single-Center Experience
Mouse models of pediatric high-grade gliomas with MYCN amplification reveal intratumoral heterogeneity and lineage signatures
How I treat recurrent pediatric high-grade glioma (pHGG): a Europe-wide survey study
How I treat recurrent pediatric high-grade glioma (pHGG): a Europe-wide survey study
Computational multi-omics analysis of pediatric DADDR patients and synthetic lethality prediction in K27M mutated pediatric high-grade glioma
Multifocal high-grade glioma radiotherapy safety and efficacy
The pediatric supratentorial MYCN-amplified high-grade gliomas methylation class presents the same radiological, histopathological and molecular features as their pontine counterparts
Capmatinib is an effective treatment for MET-fusion driven pediatric high-grade glioma and synergizes with radiotherapy
A prognostic neural epigenetic signature in high-grade glioma
Refinement of diagnostic criteria for pediatric-type diffuse high-grade glioma, IDH- and H3-wildtype, MYCN-subtype including histopathology, TP53, MYCN and ID2 status
An integrative radiological, histopathological and molecular analysis of pediatric pontine histone-wildtype glioma with MYCN amplification (HGG-MYCN)
Signaling pathways and mesenchymal transition in pediatric high-grade glioma
Pediatric Non–Brain Stem High-Grade Glioma: A Single-Center Experience
Mouse models of pediatric high-grade gliomas with MYCN amplification reveal intratumoral heterogeneity and lineage signatures
How I treat recurrent pediatric high-grade glioma (pHGG): a Europe-wide survey study
How I treat recurrent pediatric high-grade glioma (pHGG): a Europe-wide survey study
Computational multi-omics analysis of pediatric DADDR patients and synthetic lethality prediction in K27M mutated pediatric high-grade glioma
Multifocal high-grade glioma radiotherapy safety and efficacy
The pediatric supratentorial MYCN-amplified high-grade gliomas methylation class presents the same radiological, histopathological and molecular features as their pontine counterparts
Capmatinib is an effective treatment for MET-fusion driven pediatric high-grade glioma and synergizes with radiotherapy